About Neurix

After studying stem cells at the Imperial College London, Nikolay gained valuable finance experience at UBS and J.P.Morgan. Nikolay is involved with numerous pharmaceutical startups and has vast contacts in the banking, biotechnology and pharmaceuticals domains. He provides grounded strategy and forward thinking for the development and success of Neurix.

Karl-Heinz is Professor of Medicine at the Faculty of Medicine & University Hospitals of Geneva, as well as honorary professor at the Bejing Hospital, China. Karl-Heinz has been actively involved in inflammation research. Since 1998, he focused his research further on mechanisms of aging and treatment of age-associated diseases. He is an elected member of the Swiss Academy of Medical Sciences, the American Society for Clinical Investigation, and founder of 6 startups.

Beat is a Professor Emeritus in the Department of Pathology & Immunology at the University of Geneva, where he was previously Head of Department. His continued research interests are in the pathology of leukocyte migration in inflammatory diseases & tumor angiogenesis, as well as in drug development. He has also held roles as President of the Swiss Society Allergology & Immunology, & European Society of Microcirculation. He has over 180 publications & patents.

Carla is a PhD-trained immuno-oncologist with experience in stem cell biology, 3D modeling, and personalized medicine. With a strong academic foundation, she has led translational cancer research projects across Europe. At Neurix SA, she serves as an R&D Scientist, where she develops advanced human iPSC-derived brain organoid models to study neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and glioblastoma.

Aurore is a biotechnology researcher with broad experience in molecular and stem cell biology. She previously worked at Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, France, where she contributed to stem cell therapy program for Huntington’s Disease. She developed protocols for deriving human and monkey pluripotent stem cells and differentiating them into striatal progenitors and neurons. She then joined University of Geneva and later Neurix, currently developing 3D models of neurodegenerative diseases.